Sector movers: Diageo drags beverage stocks lower on emerging-market concerns
30th Jan 2014 15:26
Drinks manufacturer Diageo was dragging the beverage sector into the red on Thursday as investors reacted negatively to the company's first-half results which missed analysts' expectations. The company, famous for its Johnnie Walker and Guinness brands, reported a 3% fall in volumes in the first ha
Read moreThursday broker round-up UPDATE
30th Jan 2014 09:06
Amedeo Resources: Daniel Stewart initiates with a target price of 2p and a buy recommendation. Anglo American: Credit Suisse ups target price from 1600p to 1650p and leaves its neutral rating unchanged. Antofagasta: Citi takes target price from 270p to 290p, but still recommends selling. JP Morgan
Read moreLondon pre-open: FTSE to jump after Turkish interest rate decision
29th Jan 2014 07:14
- Turkish central bank ups interest rate to 12 per cent - Fed announcement due later today - German consumer confidence rises City sources predict the FTSE 100 will open 39 points above yesterday's close of 6,572.33, boosted by the Turkish central bank's decision to increase interest rates last nig
Read moreBetter international business drives up revenue at Britvic
29th Jan 2014 07:00
A strong rise in international business drove higher first quarter revenue at Britvic as the soft drinks group reported second quarter trading ahead of last year. Britvic's international revenue rose 5.6% in the 12 weeks to December 22nd, underpinning a 1.3% lift in group revenue to £311.8m at cons
Read moreThursday broker round-up UPDATE
16th Jan 2014 08:59
Aberdeen Asset Management: Canaccord Genuity cuts target price from 586p to 540p, while its buy recommendation remains unchanged. Anglo American: UBS ups target price from 1500p to 1580p upgrading from neutral to buy. Antofagasta: Investec reduces target price from 716p to 685p maintaining a sell
Read moreBroker tips: GlaxoSmithKline, Serco, Britvic
19th Dec 2013 12:23
Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. "Sandoz/Vectura's EU branded generic of Advair/Seretide was anticipated, though the timing was uncertain. Confirmation of its approval
Read moreBroker snap: Britvic 'up with events', says Investec
19th Dec 2013 10:42
Britvic shares are 'up with events' after a strong run, according to Investec which reiterated a 'hold' recommendation on the soft drinks group on Thursday. "It has been a remarkable 2013 for Britvic, with its price looking set to close the year some 65% ahead," said analyst Nicola Mallard. "Opti
Read moreThursday broker round-up UPDATE
19th Dec 2013 08:27
AstraZeneca: Alphavalue lowers target price from 3169p to 3087.7p and downgrades from reduce to sell. British American Tabacco: Panmure Gordon reduces target price from 3800p to 3200p and downgrades from buy to hold. Britvic: Investec ups target price from 600p to 672p and maintains a hold recomme
Read moreWednesday broker round-up UPDATE
27th Nov 2013 09:14
Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu
Read moreLondon close: Mining stocks drag FTSE 100 lower
26th Nov 2013 16:29
- Mining stocks track metals prices lower - Economic data from the US comes in mixed - BTG jumps on US approval of Varithena techMARK 2,649.54 -0.07% FTSE 100 6,636.22 -0.87% FTSE 250 15,306.13 +0.04% Weakness in the mining sector kept markets firmly in the red on Tuesday as a lack of newsflow and
Read moreSABMiller Chairman reduces family trust's holding
26th Nov 2013 12:41
Graham Mackay, the Chairman of drinks giant SABMiller, reduced his beneficial interest in the company after the E.A.G Mackay Family Trust sold 15,370 shares. The £499,986 disposal, which saw the shares sold at 3,253p each, reduced Mackay's stake to just under 1.4m shares. Meanwhile, Non-Executive
Read moreLondon midday: Stocks fall as investors await US data
26th Nov 2013 11:28
- Thanksgiving holiday to affect trading volumes - BTG jumps after Varithena approval - De La Rue, Mitchells & Butlers, Britvic gain after results - Glencore Xstrata drops on Las Bambas developments techMARK 2,652.61 +0.05% FTSE 100 6,663.62 -0.46% FTSE 250 15,343.14 +0.28% UK stocks headed slight
Read moreLondon open: Stocks head lower ahead of quiet day
26th Nov 2013 08:31
- Thanksgiving holiday to affect trading volumes - Britvic, De La Rue, Mitchells & Butlers gain after results - Severn Trent delivers flat first half techMARK 2,647.48 -0.15% FTSE 100 6,682.98 -0.17% FTSE 250 15,321.35 +0.14% UK markets opened slightly lower on Tuesday morning as investors showed
Read moreBritvic toasts revenue rise, ramps up US expansion
26th Nov 2013 07:07
- Full-year revenue rise - Expands Fruitshoot in the US - Eyes improved trading despite challenging consumer environment Soft drinks maker Britvic delivered improved full-year revenue as it continues to push through cost saving initiatives and as it increases its Fruit Shoot brand in the US. The
Read moreTuesday preview: BoE's Carney provides evidence on Inflation Report
25th Nov 2013 14:58
Bank of England (BoE) Governor Mark Carney will on Tuesday give evidence to MPs on the central bank's latest quarterly Inflation Report. In the Inflation Report, released earlier this month, the BoE said that higher borrowing costs would depend on various factors such as the labour market. The b
Read more